In vitro amplification of ovine prions from scrapie-infected sheep from Great Britain reveals distinct patterns of propagation by Leigh Thorne et al.
Thorne et al. BMC Veterinary Research 2012, 8:223
http://www.biomedcentral.com/1746-6148/8/223RESEARCH ARTICLE Open AccessIn vitro amplification of ovine prions from
scrapie-infected sheep from Great Britain reveals
distinct patterns of propagation
Leigh Thorne1, Thomas Holder1, Andrew Ramsay1, Jane Edwards1, Maged Mohamed Taema2, Otto Windl1,
Ben Charles Maddison3, Kevin Christopher Gough2 and Linda Ann Terry1,4*Abstract
Background: Protein misfolding cyclic amplification (PMCA) is a method that facilitates the detection of prions
from many sources of transmissible spongiform encephalopathy (TSE). Sheep scrapie represents a unique diversity
of prion disease agents in a range of susceptible PRNP genotypes. In this study PMCA was assessed on a range of
Great Britain (GB) sheep scrapie isolates to determine the applicability to veterinary diagnosis of ovine TSE.
Results: PrPSc amplification by protein misfolding cyclic amplification (PMCA) was assessed as a diagnostic tool for
field cases of scrapie. The technique was initially applied to thirty-seven isolates of scrapie from diverse
geographical locations around GB, and involved sheep of various breeds and PRNP genotypes. All samples were
amplified in either VRQ and/or ARQ PrPC substrate. For PrPSc from sheep with at least one VRQ allele, all samples
amplified efficiently in VRQ PrPC but only PrPSc from ARH/VRQ sheep amplified in both substrates. PrPSc from ARQ/
ARQ sheep displayed two amplification patterns, one that amplified in both substrates and one that only amplified
in ARQ PrPC. These amplification patterns were consistent for a further 14/15 flock/farm mates of these sheep.
Furthermore experimental scrapie strains SSBP1, Dawson, CH1641 and MRI were analysed. SSBP1 and Dawson (from
VRQ/VRQ sheep) amplified in VRQ but not ARQ substrate. MRI scrapie (from ARQ/ARQ sheep) nor CH1641 did not
amplify in ARQ or VRQ substrate; these strains required an enhanced PMCA method incorporating polyadenylic acid
(poly(A)) to achieve amplification.
Conclusions: PrPsc from 52 classical scrapie GB field isolates amplified in VRQ or ARQ or both substrates and
supports the use of PMCA as a rapid assay for the detection of a wide range of ovine classical scrapie infections
involving multiple PRNP genotypes and scrapie strains.
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Transmissible spongiform encephalopathies (TSEs) or
prion diseases are a group of fatal neurodegenerative dis-
orders which include Creutzfeldt–Jakob disease (CJD)
and Kuru in humans, bovine spongiform encephalopathy
(BSE) in cattle, scrapie in sheep and goats and chronic
wasting disease (CWD) in deer and elk. Experimental
evidence supports the concept that the causative agent is* Correspondence: linda.terry@unige.ch
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reproduction in any medium, provided the orcomprised of a misfolded isoform (PrPSc) of the normal,
ubiquitously expressed cellular protein, PrPC [1]. The
two proteins are of identical primary sequence and share
the same posttranslational modifications yet are distinct
in their physicochemical properties. The detection of
accumulated PrPSc following post-mortem is a reliable
marker for the presence of infection and forms the basis
of the majority of diagnostic tests. Currently there is no
cure or treatment for these diseases and the develop-
ment of high throughput diagnostics to detect disease
prior to the onset of clinical signs are still required. To
date there are no validated blood tests for sheep scrapie
and the most promising pre-mortem tests involve biopsyLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(IHC) examination [2,3].
Conversion of PrPC in vivo is presumed to occur fol-
lowing direct interaction with the pathogenic protein,
which acts as a template to drive the conformational
change to PrPSc. Sustained propagation, largely in the
central nervous system, results in the accumulation and
deposition of the pathogenic protein. This conversion
can be reproduced in vitro using the technique protein
misfolding cyclic amplification (PMCA) which was pio-
neered by Soto and colleagues [4]. PMCA allows propa-
gation of PrPSc in vitro from very small amounts of
undetectable seeding material to quantities sufficient for
detection by Western blot or plate-based immunoassays.
This ultra-sensitive method has been previously applied
to identify prions in a wide range of tissues and fluids
from scrapie-infected sheep (blood, faeces, saliva and
milk) where only small amounts of the infectious agent
reside [5-9]. Given its unique ability to detect prions in
readily accessible tissues and at preclinical stages of the
disease it presents a viable method for a live animal, pre-
clinical test for prion disease.
The application of PMCA to detect PrPSc from
infected sheep had previously been focused on infected
sheep with highly susceptible genotypes and from a sin-
gle endemic scrapie infected flock. The data from these
studies showed that pre-mortem and pre-clinical testing
for prion diseases could be achieved [5-9]. However,
these studies were not representative of the diversity of
scrapie strains or PRNP genotypes observed in sheep.
Within the present study we aimed to determine
whether scrapie from diverse locations and PRNP geno-
types in Great Britain (GB) could be amplified in vitro
and therefore whether PMCA could be used universally
as a putative diagnostic tool for a wide range of primary
isolates of classical scrapie.
Results
Amplification of classical scrapie field isolates by PMCA
Prions derived from brain tissue from sheep infected
with classical scrapie of 8 different PRNP genotypes (at
codons 136, 141 and 154) were used to seed PMCA
reactions. These amplifications used either VRQ homo-
zygous and/or ARQ homozygous brain substrates from
prion-free sheep as a source of PrPC for conversion. A
total of 37 sheep were initially tested from diverse geo-
graphical regions of GB and from at least 20 different
farms (Table 1). All field cases were from 1997–2007
and were confirmed as scrapie-positive by three inde-
pendent diagnostic tests; the Bio-Rad TeSeE immuno-
assay, the hybrid Western Blot developed at the AHVLA
[10] and immunohistochemistry (IHC) of formalin-fixed
paraffin-embedded sections. All of these cases displayed
characteristics of classical scrapie when analysed byWestern blot and IHC (as reported for statutory diagno-
sis, data not shown).
All 37 samples amplified in vitro by serial PMCA in ei-
ther the VRQ or the ARQ substrate or both (Table 1)
after 4 rounds. Samples from sheep possessing at least
one VRQ allele (18 isolates) amplified in a VRQ sub-
strate. Furthermore, with the exception of ARH/VRQ
sheep, none of these samples amplified in an ARQ
homozygous substrate (11 out of 15 isolates tested). This
observation indicates that homology for the amino acid
at position 136 between seed and substrate may be
required for the amplification of some isolates as previ-
ously suggested [9]. The ARH/VRQ infected sheep,
PrPSc amplified in both VRQ and ARQ homozygous sub-
strates (4 isolates). It is unclear whether this is related to
the presence of the ARH allele or the identity of the iso-
late, given that these samples all came from the same
farm. However, the effects of the ARH genotype appears
the more likely explanation as the presence of the ARH
allele (14 isolates) promoted amplification of PrPSc in
both VRQ and ARQ substrates irrespective of the pres-
ence of a heterologous allele. This included ARH sam-
ples from geographically distinct farms.
Samples from seven ARQ/ARQ sheep were tested and
all amplified readily in the ARQ substrate in agreement
with previous observations [9]. However, when the
ARQ/ARQ scrapie samples were tested in the VRQ sub-
strate, heterogeneity of amplification was observed.
Three out of six samples were also amplified in VRQ
substrate. These samples were evaluated several times in
order to verify this heterogeneity. No variation in the
amplification pattern was seen when three PMCA sub-
strates of the same genotype but from different sheep
were used. The farms from which the two patterns
emerged were not geographically close. The two AHQ/
AHQ samples tested amplified only in the ARQ
substrate.
Western blot analysis was performed on selected sam-
ples and showed that the molecular mass profiles
remained unchanged following amplification of classical
scrapie isolates of distinct PRNP genotypes in either
ARQ or VRQ homozygous substrate (Figure 1). The dis-
tinct three-band pattern corresponding to the di-,
mono- and un- glycosylated PK resistant PrPsc moieties
were clearly observed and the molecular mass of the un-
glycosylated bands were indistinguishable.
The distinct patterns of amplification observed for
the ARQ/ARQ seeds, i.e. ability to amplify in VRQ and
ARQ or ARQ alone, were investigated further. Four
farms were identified where additional samples were
available; three for which the ARQ/ARQ scrapie sam-
ples amplified in both ARQ and VRQ substrates (913/
05, 1230/04 and 960/06) and one farm where the ori-
ginal tested isolate amplified in ARQ substrates alone
Table 1 In vitro PMCA amplification of sources of GB scrapie
Sheep ID PrnP genotype Farm Geographic Location* Age at death Amplification in substrates
VRQ ARQ
1597/98 VRQ/VRQ 1 E. England 2y 7 m + -
322/97 2 Wales 2y 0 m + -
1563/02 3 W. England 2y 8 m + -
836/03 4 S. England 2y 2 m + -
1276/02 5 Wales 2y 0 m + ND#
2413/98 6 W. England 2y 2 m + ND
456/03 ARQ/VRQ 7 N. England 3y 0 m + -
455/03 7 N. England 6y 0 m + -
615/03 7 N. England 5 y 0 m + -
226/03 7 N. England 5y 0 m + -
ss2-022278 8 W. England not known + -
219/06 ARH/VRQ 17 W. England 2y 0 m + +
252/06 17 W. England 2y 0 m + +
198/06 17 W. England 2y 0 m + +
216/06 17 W. England 2y 0 m + +
989/02 ARR/VRQ 9 S. England 8y 0 m + ND
ss4 506045 10 N. England not known + -
ss4-506228 not known not known not known + -
297/97 ARQ/ARQ 11 S. England not known - +
ss4-012265 10 N. England not known - +
913/05 12 W. England 5y 0 m + +
522 not known not known not known ND +
960/06 13 W. England 7y 0 m + +
1341/04 14 E. England 5y 5 m - +
1230/04 15 Scotland 2y 4 m + +
284/97 AHQ/AHQ 11 S. England not known - +
1091/01 16 Midlands 4y 8 m - +
217/06 ARH/ARH 17 W. England 1y 0 m + +
429/06 17 W. England 2y 0 m + +
1731/03 ARH/ARQ 18 N. England 1y 6 m + +
1741/03 18 N. England 1y 2 m + +
1952/04 19 W. England 3y 0 m + +
936/05 20 Wales 4y 0 m + +
708/02 15 Scotland 5y 0 m + +
399/04 15 Scotland 3y 0 m + +
462/04 15 Scotland 2y 0 m + +
915/07 13 S. England 1y 6 m + +
*S. England: South of England, N. England: North of England, W. England: Welsh borders and West Country, E. England: East of England. All samples were analysed
in duplicate after four rounds of PMCA and those marked + were positive in at least one replicate. #ND, not done.
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infected farm/flock mates tested maintained the ampli-
fication profile of the initial cases (Table 2). The sheep
were from geographically distant farms and from seven
different sheep breeds. Furthermore, flock/farm matescarried prions with similar in vitro amplification char-
acteristics. There was one exception to this observation.
Isolate 210/03 amplified in both substrates whereas the
other 7 sheep tested from this farm only amplified in
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Figure 1 Amplification by in vitro PMCA of field sources of
scrapie of sheep with different PRNP genotypes. Unamplified
samples (−) or amplified for 4 rounds of PMCA (+) were analysed by
Western blot. VRQ/VRQ scrapie 836/03 (lanes 1 and 2) and 1276/02
(lanes 3 and 4) and ARQ/ARQ scrapie 960/06 (lanes 5–7), ARH/VRQ
scrapie 252/06 (lane 10–12), ARH/ARH 429/06 scrapie (lanes 13–15)
were amplified in VRQ/VRQ substrate (lanes 2, 4, 6, 11 and 14) or
ARQ/ARQ substrate (lane 7,12 and 15). Lanes 8 and 9: unamplified
controls of classical scrapie (lane 8) and experimental ovine BSE
(lane 9). PrP was visualised with Sha31 antibody. Molecular mass
markers are indicated (kDa). In all lanes wet tissue equivalent of
0.3 mg was loaded.
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sheep (1684/97 and 1927/99) produced prion that was
amplified in ARQ but not VRQ substrate. This is dif-
ferent from the pattern of amplification that we
observed for ARQ/VRQ scrapie sources as shown in
Table 1.
WB analysis of PK-resistant PrPSc from the sheep from
farm 11, in which heterogeneity was observed, either be-
fore or after PMCA amplification was not able to distin-
guish these scrapie field isolates from each other
(Figure 2). Furthermore, the molecular masses of the
amplified products from sample 210/03 amplified in ei-
ther substrate were indistinguishable. Overall, the PMCA
data suggest that the amplification patterns in distinct
PrPC substrates are likely to be influenced by the specific
isolate or strain as well as complementarity of the seed
and substrate at specific residues. Evidence from bioas-
says in wild type and transgenic mice from scrapie iso-
lated from several GB farms suggests that more than
one strain is present in some flocks [11] and this could
also explain the heterogeneity of amplification observed
from this farm.Amplification of classical scrapie in ARQ/VRQ substrates
As part of the evaluation of PMCA as a potential diag-
nostic we also addressed the possibility of a universal
substrate. Since all isolates tested replicated in VRQ or
ARQ or both substrates we tested the amplification of
four of each of the ARQ/ARQ and VRQ/VRQ homozy-
gous PrPSc samples in an ARQ/VRQ substrate. As
shown in Table 3 the VRQ/VRQ isolates amplified read-
ily in the heterozygous substrate. However, the ARQ/
ARQ seeds did not amplify consistently. It is unclear
whether this is an inhibitory effect of the VRQ PrPC on
amplification of ARQ PrPSc or whether the reduction in
the amount of ARQ PrPC available in heterozygote sub-
strates decreased the efficiency of amplification. The
results of amplification studies using homozygous sub-
strates mixed in different ratios were ambiguous and
were not able to clearly identify a cause (data not
shown). What is evident is that the ARQ/VRQ brain
substrates cannot be consistently used as a universal
source of PrPC for PMCA studies or diagnostics.
In vitro amplification characteristics of known scrapie
strains
The observation that the amplification of some scrapie
field isolates is not exclusively determined by a match at
codon 136 between seed and substrate suggested to us
that the scrapie strain my also influence in vitro PrPsc
replication. Others have reported more than 15 distinct
scrapie strains in the GB national flock, mostly identified
only by disease characteristics following passage in con-
genic mice [12]. Currently no diagnostic tests are able to
identify these strains in the original host. Previously we
demonstrated differences in amplification patterns be-
tween experimental BSE and the scrapie strain CH1641
[13] providing evidence that different prion strains influ-
ence replication patterns in vitro. Whether other scrapie
strains also influence the amplification pattern was
assessed here using known strains/sources of ovine
prions (Table 4). The classical strains, Dawson, SSBP1
and MRI Suffolk scrapie display the typical classical scra-
pie molecular phenotype; a high relative molecular mass
un-glycoslyated band, which is reactive to the N-
terminal antibody P4. Dawson and SSBP1 scrapie, pro-
pagated in VRQ/VRQ sheep, amplified readily in VRQ
substrates but not the ARQ substrates. This is consistent
with the observations made with the VRQ/VRQ field
isolates. All amplified samples retained their molecular
phenotypes upon amplification by PMCA (Figure 3A).
However, a scrapie strain from the Moredun Research
Institute (MRI) Suffolk flock that propagates in ARQ/
ARQ sheep that has characteristics consistent with a sin-
gle strain [14,15] did not amplify readily in either the
VRQ or the ARQ substrates (Table 4). This strain has
very distinct transmission characteristics in rodents [16]
Table 2 PMCA-amplification of infected flock/farm mates of ARQ/ARQ scrapie-infected sheep
Farm* Sheep ID Breed Age at death PMCA substrates#
VRQ/VRQ ARQ/ARQ
12 913/05 Mule 5y 0 m + +
SS0-560272 Suffolk Cross 4y + +
15 1230/04 Suffolk Cross 2y 4 m + +
709/02 Cheviot/Shetland 5y + +
768/02 Cheviot/Shetland 4y + +
857/04 Cheviot/Shetland 7y 3 m + +
858/04 Cheviot/Shetland 3y 3 m + +
872/04 Cheviot/Shetland 7y 3 m + +
13 960/06 White Face Dartmoor 7y + +
703/07 White Face Dartmoor 6y + +
912/07 White Face Dartmoor 7y + +
11 297/97 Finn Dorset not known - +
210/03 Warborough 2y 2 m + +
209/03 Warborough 5y 1 m - +
1583/97 Finn Dorset 4y - +
1685/97 Finn Dorset 4y - +
1002/03 Finn Dorset Cross 7y - +
1158/00 Finn Dorset 6y - +
57/99 Finn Dorset 5y 1 m - +
*Farms 12, 15, 13 and 11 were located in Gloucestershire, Aberdeenshire, Devon and Oxfordshire respectively. Samples were analysed after 4 rounds of PMCA.
#Each sample was amplified twice using a single substrate of each genotype and a positive sample was recorded when positive in at least one replicate.
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Italian strain [17]. These characteristics were not identi-
fied in any of the field isolates we tested here. These data
support observations that this strain of scrapie is poorly
represented in the GB flock [18]. We were also unable
to detect amplification of samples from 7 sheep with
atypical scrapie. The animals tested had ARQ or ARR
homozygous PRNP genotypes.M   209/03 1583/97 210/03 




Figure 2 Amplification of prions from ARQ/ARQ scrapie-
affected flock/farm mates of scrapie-infected sheep, 297/97.
Unamplified samples (lanes 1, 3 and 6) or amplified for 4 rounds in
ARQ/ARQ substrate (lanes 2, 4 and 8) or VRQ/VRQ substrate (lane 7).
Molecular mass markers are shown (M, kDa). Unseeded ARQ/ARQ
substrate subjected to PMCA amplification is shown in lane 5. In all
lanes 0.3 mg wet tissue equivalent loaded per lane).In vitro amplification of sources of ovine scrapie
refractory or weakly amplified by the standard PMCA
method
To determine the amplification requirements of the
strains that did not amplify in VRQ or ARQ substrates,
we attempted amplifying in the presence of Poly(A) and
in ARQ, VRQ and AHQ homozygous PRNP genotype
substrates. Successful amplifications were observed for
MRI scrapie in ARQ/ARQ and AHQ/AHQ but not
VRQ substrate with the addition of Poly(A) (Table 5,
Figure 3B). To date we have been unable to confirm
amplification of atypical scrapie in vitro even with
enhanced PMCA protocols.
CH1641 scrapie is an experimental strain with similar
molecular traits to rare field isolates, termed CH1641-
like, and is typified by a low molecular mass un-
glycosylated band upon PK- digestion that is bound
weakly/not at all by P4 antibody [10]. In our previous
study we demonstrated that CH1641 scrapie was refrac-
tory to PMCA amplification in AHQ and VRQ sub-
strates over 5 PMCA rounds [13]. Here, amplifications
of this strain in ARQ substrate also failed to yield PrPSc
over 4 rounds (data not shown). However, CH1641 was
amplified in ARQ, VRQ and AHQ substrates with the
addition of Poly(A) retaining the molecular phenotype
after amplification in all substrates (Table 5, Figure 3B).
Table 3 PMCA amplification in an ARQ/VRQ substrate
Seed Substrate
VRQ/VRQ# ARQ/ARQ# ARQ/VRQ1* ARQ/VRQ2* ARQ/VRQ3*
VRQ/VRQ1 + - +/+/+/+ +/+/+/+ +/+/+/+
ARQ/ARQ1 - + −/−/−/− −/−/−/− +/−/−/−
*For each of the amplifications performed using the heterozygous substrates four different scrapie sources were used and tested once in each of the substrates.
#The control amplifications performed in homozygous substrates used only one of these seeds. +/− symbols show the amplification outcome for each animal.
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PrPSc in vitro amplification characteristics, which are
likely to be influenced by the scrapie strain.
Discussion
In this study we sought to determine whether the PrPSc
from scrapie infected sheep with diverse PRNP geno-
types and from different locations in Great Britain could
be amplified in vitro using the highly sensitive technique
PMCA. All 37 of the individual field isolates of classical
scrapie initially tested, with a further 15 flock mates,
amplified in vitro in the presence of either a VRQ/VRQ
or an ARQ/ARQ substrate or both. The physicochemical
properties of the amplified products appeared to remain
unchanged upon in vitro replication thus facilitating a
reliable diagnosis on analysis of the converted product.
These data indicate that PMCA could be a useful means
of diagnosis in the field despite the variation of PRNP
genotypes affected and the reported high variation in
scrapie strains. However, it should be noted that two ex-
perimental scrapie strains, MRI and CH1641, were not
amplified efficiently using the standard PMCA method-
ology and when using distinct PrPC genotype substrates.
This may indicate that whilst the more common scrapie
strains found in Great Britain can be detected by this
methodology, other more infrequent strains are not
detected. The addition of poly(A) to the PMCA reac-
tions is known to increase the sensitivity of the method
for ovine scrapie [9], this enhanced PMCA did indeed
yield positive amplifications for both MRI and CH1641.
These data indicate that in order to use PMCA to screen
for a wide range of common and rare scrapie isolates
when present within multiple distinct PRNP genotypes,
the use of VRQ and ARQ substrates as well as enhanced
amplification techniques may be required.Table 4 Amplification of experimental and natural strains of
Strain Genotype
SSBP1 (n = 1) VRQ
Dawson (n = 1) VRQ
MRI Suffolk (n = 3) ARQ
Atypical scrapie (n = 7) ARQ (n = 5) or ARR (n = 2)
n = number of animals tested. Samples were tested in duplicate in separate assays
AFRQ/AFRQ genotype is more commonly associated with atypical scrapie [19]. ND =The data illustrate obvious effects of both substrate
and seed PRNP genotypes on the ability to amplify in
different in vitro conditions. PrPSc from sheep with one
or more VRQ alleles was efficiently amplified in VRQ
substrate but not in ARQ substrate. The exception was
ARH/VRQ PrPSc, which amplified efficiently in both
substrates. Indeed, this appears to be a trait of PrPSc pro-
duced in sheep with at least one ARH allele, as all such
PrPSc was consistently amplified in both substrates.
The amplification of PrPSc from animals with an ARQ
genotype produced two distinct amplification patterns,
some isolates amplified efficiently in both ARQ and
VRQ substrates whilst others amplified only in ARQ
PrPC. 14/15 flock/farm mates of four of these sheep with
ARQ/ARQ genotypes had PrPSc with the same amplifi-
cation characteristics supporting the hypothesis that
in vitro replication could be influenced by the strain or
source of scrapie. This supports the previously published
observation that ovine BSE and CH1641 scrapie have
distinct PMCA-amplification patterns in distinct sub-
strates despite sharing almost indistinguishable molecu-
lar characteristics [13].
As mentioned, the data show that some isolates can
display promiscuous conversion within either ARQ or
VRQ substrates while others display a preference for one
or the other. Further investigations might determine
whether this preference, or lack of, also occurs in vivo
and whether conversion of PrPC in the host is reflected
by the observation in vitro.
Sheep are known to have been infected with classical
scrapie in Great Britain for over 200 years. Much re-
search, based on transmission characteristics to inbred
mice, has identified more than 15 classical scrapie iso-
lates with distinct pathologies [12]. A proportion of this







*AFRQ/AFRQ substrate where F represents amino acid at position 141. The
not done. +/− symbols show the amplification outcome for each animal.
















Figure 3 MRI Suffolk and CH1641 scrapie amplified in the presence of poly(A) in substrates with different PRNP genotypes. Unamplified
samples (lanes 1) or amplified (0.3 mg wet tissue equivalent loaded per lane) in VRQ/VRQ substrate (lanes 2), ARQ/ARQ substrate (lanes 3 and 4)
or AHQ/AHQ (lanes 5) in the presence of Poly(A). Lane 6 contains products amplified in AHQ/AHQ substrate in the absence of Poly(A). All
amplifications were analysed after 4 rounds. Molecular mass markers are indicated (kDa). Upper panels are visualised with Sha31 and lower panels
with P4 antibodies.
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population. Differences in in vitro efficiency of conver-
sion could mirror in vivo conversion as previously
described [20]. From the strains analysed in the present
study, it is interesting that both CH1614 and MRI scra-
pie are poorly transmitted to inbred laboratory mice
[17,21] and neither amplified in vitro under standard
conditions. MRI scrapie transmits to mice transgenic for
both ovine ARQ and VRQ but with prolonged incuba-
tion times while Dawson and SSBP1 transmit to VRQ
transgenic mice with short incubation periods of ap-
proximately 65 days (unpublished data). BSE, however,
has been transmitted to sheep with ARQ, ARR and VRQ
genotypes, to inbred mice and mice transgenic for ovine
ARQ and VRQ alleles. In vitro, ovine BSE is readily
amplified under standard PMCA conditions in ARQ,
VRQ and AHQ substrates [13]. Thus there is some con-
formity between biological characteristics and in vitro
amplification efficiencies of distinct strains.
Currently only BSE, to which sheep are known to be
highly susceptible experimentally, is known to be zoo-
notic but fortunately only a small number of cases haveTable 5 Amplification of MRI, CH1641 and atypical scrapie str
Strain Genotype
AR
MRI scrapie ARQ/ARQ (n = 3) +/+
CH1641 AHQ/AHQ (n = 3) +/+
Atypical scrapie ARQ/ARQ (n = 5) −/−/−
AHQ/AHQ (n = 2) −/−
ARQ/AHQ (n = 7) −/−/−/−
n = number of animals tested. Poly(A) was added to the amplification reactions and
duplicate except for atypical scrapie samples amplified in ARQ and AHQ substrates
outcome for each animal.been identified in small ruminants, and these were in
goats [22-24]. However, in the absence of precise tools
to identify a strain in the natural host it is unclear
what scrapie diversity could represent in terms of cross
species transmission and zoonosis. PMCA could prove
a useful tool to aid strain identification as a primary in-
vestigation prior to bioassay. In addition, the presented
data indicate that PMCA could be a valuable method
for the rapid diagnosis of classical scrapie in field iso-
lates of a wide range of genotypes. Given the exquisite
sensitivity of PMCA and its applicability to readily ac-
cessible biological samples, the technique may well pro-
vide a pre-mortem, preclinical test for classical ovine
scrapie.Conclusions
PrPsc from 52 classical scrapie GB field isolates amplified
in VRQ or ARQ or both substrates and supports the use
of PMCA as a rapid assay for the detection of a wide
range of ovine classical scrapie infections involving mul-








the amplifications were carried out for 4 rounds. All analyses were in
which were analysed in single reactions. +/− symbols show the amplification
Thorne et al. BMC Veterinary Research 2012, 8:223 Page 8 of 10
http://www.biomedcentral.com/1746-6148/8/223Methods
Ovine scrapie isolates
Frozen brain tissue, either medulla or cerebellum, from
field isolates of ovine scrapie were obtained from the
biological archive (formerly the TSE archive) at AHVLA.
Initially, a total of 37 ovine classical scrapie cases repre-
senting 8 different PRNP genotypes (at codons 136, 154
and 171) and a diverse range of breeds and geographical
locations throughout the whole of GB were assessed.
Tissue (200 mg) was homogenised in PMCA conversion
buffer [PBS containing 150 mM NaCl, 4 mM EDTA
pH8.0, 1.0% (v/v) Triton X-100 and mini-complete pro-
tease inhibitor (Roche)] to give a 10% (w/v) homogenate
and stored in 20 μl aliquots at −80°C until required. All
the sheep were clinically positive and were submitted to
the AHVLA. Scrapie was confirmed positive in all iso-
lates by approved statutory methods and reported as
part of the surveillance programme. Genotypes of the
sheep were verified as described [19].
Known scrapie strain isolates were obtained from vari-
ous sources. Atypical scrapie isolates were identified as
part of the active and passive surveillance in GB and
sourced through the biological archive group (AHVLA);
CH1641 (AHQ/AHQ) strain and SSBP1 were kindly
provided by Nora Hunter (Roslin Institute, Scotland)
and inoculated at the AHVLA in AHQ/AHQ and VRQ/
VRQ sheep respectively for the preparation of additional
tissue. Dawson (VRQ/VRQ) strain also called PG127,
originating from a Cheviot-Welsh breed VRQ homozy-
gous British scrapie case, was previously serially pas-
saged and characterised [25] and was kindly provided by
Olivier Andreoletti (INRA-ENVT). MRI Suffolk scrapie
(ARQ/ARQ) was provided by colleagues at the Moredun
research institute (Scotland) and was propagated in a
closed flock [14,15] and believed to be a single strain
that resembles that identified in Italy [17].
Preparation of PMCA substrates
PMCA substrates as a source of PrPc were prepared
from brain tissue from New Zealand derived scrapie free
sheep. Whole brains were removed from adult sheep im-
mediately after euthanasia. Meninges, large blood vessels
and blood clots were removed prior to washing in ice-
cold PMCA conversion buffer. Tissues were liquidised in
ice-cold conversion buffer to give 10% (w/v) homoge-
nates then stored as 1 ml aliquots at −80°C until
required. Immediately prior to use substrates were
thawed and large particulates removed by centrifugation.
Serial protein misfolding cyclic amplification
The serial PMCA procedure was performed as described
previously [9]. In brief, tissue samples prepared as 10%
(w/v) homogenates (10-1) in PMCA conversion buffer
were diluted to 10-3 to 10-4 (to achieve an absorbancereading of approximately 0.5 units in the enzyme im-
munoassay in order to standardise the amount of PrPsc
in each assay for each brain sample) in PMCA substrate.
Diluted samples (100 μl) were placed in 200 μl PCR
tubes and subjected to repeated cycles of alternating per-
iods of sonication (40 seconds; 250 W power) and incu-
bation (29 minutes 20 seconds), performed at 37°C using
an ultra-sonic water bath (Misonix S-4000) and a deep
well microtitre plate horn. After the first 24 hr round
(48 cycles) PrPC was replenished by diluting the samples
1/3 in fresh PMCA substrate and a second 24 hr round
of PMCA was initiated. The process was continued for a
total of 4 rounds, after which the final PMCA products
were stored at −20°C until analysed. Polyadenylic acid
(Poly(A)), where used, was added to the PMCA substrate
at 100 μg/ml.
Sample analysis by enzyme immunoassay (EIA)
Pre- and post PMCA samples were analysed by EIA
(IDEXX HerdChek BSE/scrapie EIA antigen test assay)
using a modified procedure. Samples were diluted 1:5 in
kit homogenization buffer then mixed 4:5 with kit plate
diluent. Sample (100 μl) was applied to the test plate
and incubated for 180 minutes at 26°C. After removal of
excess reagents using wash buffer 1, bound sample was
incubated with conditioning buffer for 10 minutes at
26°C, washed again (wash buffer 2) to remove excess re-
agent and incubated with an anti-PrP horseradish peroxid-
ase conjugate for 90 minutes at 26°C. After removal of
excess reagents using wash buffer 2, visualization of
bound PrPSc was achieved using 3,30,5,50-tetramethylben-
zidine (TMB) substrate and measured at 450 nm using a
reference filter at 620 nm (Perkin Elmer Envision 2104
multi-label reader). Positive amplification was determined
by comparing the OD of the sample from the product of
the final round of amplification with the negative controls.
Eight negative controls (scrapie free ovine brain homoge-
nates) taken through the entire amplification process were
included in each experiment. Experiments were discarded
if contamination of the negative controls was observed.
Samples were distinguished as positive if the OD of the
samples was greater than the mean of the controls + 3
standard deviations. The strength of the OD signal was
not representative of efficiency of amplification and is
therefore shown here only as positive or negative for
amplification.
The methods for determining amplification are not
quantitative in this study. Some variability was observed
between assays. It is unclear why this variability occurs
but differences between the power of the horns, deteri-
oration of horns and the compatibility between seed and
substrate could contribute to interassay differences.
However, we attempted to control for instrumental dif-
ferences by including the same positive control titrated
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amplification efficiency for each run. Thus we concluded
that large and consistent variations were likely to be
related to the seed/substrate combination.
Sample analysis by Western immunoblot
Selected products from the PMCA were also analysed by
Western blot (WB) for proteinase K (PK) resistant PrPsc.
These samples were selected randomly among those that
had a signal of >1.5 absorbance units in the EIA, repre-
sented all the genotypes or showed unusual amplifica-
tion patterns in substrates. In this regards all the ARQ/
ARQ amplified samples were evaluated by WB. Samples
with signals less than 1.5 could not be visualised on
Western Blot as the EIA is analytically more sensitive
than the WB assay for PrPsc. Samples were digested
using proteinase K (PK) (100 μg/ml final concentration)
in the presence of 0.04% (w/v) sodium dodecylsulphate
(SDS) for 60 minutes at 50°C with continuous agitation.
Digested samples were mixed with an equal volume of
sample buffer [Laemmli sample buffer (Bio-Rad) supple-
mented with 2% (w/v) SDS and 5% (v/v) 2-mercap-
toethanol] and heated at 100°C for 5 minutes before
storage at −20°C. 0.3 mg wet tissue brain equivalent in
15 μl of sample were loaded per lane and proteins sepa-
rated on 12% Bis-Tris (Criterion XT; Bio-Rad) gels be-
fore electro-transfer to activated PVDF membrane.
Unbound membrane was blocked using 5% (w/v) BSA in
PBS supplemented with 0.1% (v/v) tween20 (PBST).
Bound PrPSc was labelled with anti-PrP Sha31 monoclo-
nal antibody (Bio-Rad) or P4 (Prionics) and detected
using anti-mouse Ig conjugated to biotin with streptavi-
din peroxidase (Sigma) and visualized by chemilumines-
cence (ECL; Amersham).
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